Vanguard Group
CLOV icon

Vanguard Group’s Clover Health Investments CLOV Stock Holding History

Vanguard Group’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$55.2M Buy
23,485,912
+425,904
+2% +$1.16M ﹤0.01% 2108
2025
Q3 		$70.6M Sell
23,060,008
-1,186,026
-5% -$3.39M ﹤0.01% 1998
2025
Q2 		$67.6M Buy
24,246,034
+3,665,917
+18% +$12.1M ﹤0.01% 1991
2025
Q1 		$73.9M Buy
20,580,117
+994,904
+5% +$4M ﹤0.01% 1926
2024
Q4 		$61.7M Buy
19,585,213
+386,499
+2% +$1.38M ﹤0.01% 2077
2024
Q3 		$54.1M Buy
19,198,714
+1,853,702
+11% +$4.24M ﹤0.01% 2140
2024
Q2 		$21.3M Sell
17,345,012
-353,642
-2% -$317K ﹤0.01% 2539
2024
Q1 		$14.1M Sell
17,698,654
-6,633,026
-27% -$6.04M ﹤0.01% 2770
2023
Q4 		$23.2M Sell
24,331,680
-6,415,828
-21% -$6.3M ﹤0.01% 2528
2023
Q3 		$33.2M Sell
30,747,508
-687,192
-2% -$818K ﹤0.01% 2327
2023
Q2 		$28.2M Sell
31,434,700
-1,726,605
-5% -$1.53M ﹤0.01% 2443
2023
Q1 		$28M Buy
33,161,305
+1,002,557
+3% +$1.1M ﹤0.01% 2445
2022
Q4 		$29.9M Buy
32,158,748
+1,248,681
+4% +$1.67M ﹤0.01% 2430
2022
Q3 		$52.5M Sell
30,910,067
-1,184,945
-4% -$3.1M ﹤0.01% 2157
2022
Q2 		$68.7M Buy
32,095,012
+6,007,484
+23% +$16M ﹤0.01% 2033
2022
Q1 		$92.6M Buy
26,087,528
+200,177
+0.8% +$580K ﹤0.01% 1988
2021
Q4 		$96.3M Buy
25,887,351
+8,887,604
+52% +$54.5M ﹤0.01% 2001
2021
Q3 		$126M Buy
16,999,747
+7,469,936
+78% +$63.9M ﹤0.01% 1858
2021
Q2 		$127M Sell
9,529,811
-16,655,718
-64% -$164M ﹤0.01% 1867
2021
Q1 		$198M Buy
+26,185,529
New +$296M 0.01% 1581

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Group's CLOV Position: Q4 2025 in Review

Vanguard Group increased its Clover Health Investments (CLOV) stake by 1.8% in Q4 2025, buying an estimated $1.16M and bringing the position to 23,485,912 shares worth $55.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Vanguard Group first reported a position in CLOV in Q1 2021 and has held it in 20 quarters since. The position peaked at $198M in Q1 2021. 192 funds tracked by Wall St. Rank hold CLOV as of Q4 2025.

  • Vanguard Group held 23,485,912 shares of Clover Health Investments worth $55.2M as of Q4 2025.
  • Vanguard Group bought 425,904 Clover Health Investments shares in Q4 2025, an estimated $1.16M.
  • Clover Health Investments made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2108 holding.
  • Vanguard Group first reported a position in Clover Health Investments in Q1 2021 and has held it in 20 quarters since.
  • Vanguard Group's Clover Health Investments position peaked at $198M in Q1 2021.
  • 192 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.